Oct 15, 2025 11:00
BHVN - Biohaven Ltd.
Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
---|---|---|---|---|---|---|---|
16.68 0.69 (4.14%) | --- | --- | --- | -0.02 (-0.12%) | 0.76 (4.57%) | 0.01 (0.06%) | 0.01 (0.06%) |
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
AfterHours
Earnings & Ratios
- Basic EPS:
- -1.94
- Diluted EPS:
- -1.94
- Basic P/E:
- -8.9536
- Diluted P/E:
- -8.9536
- RSI(14) 1m:
- 0.0
- VWAP:
- 17.37
- RVol:
- 1.0025
Events
Period | Kind | Movement | Occurred At |
---|---|---|---|
1m | Price increase 1m | 17.78 +0.41 (+2.36%) | Oct 15 11:56 |
1m | Price increase 1m | 17.27 +0.29 (+1.71%) | Oct 15 09:44 |
Related News
Sep 29, 2025 17:35
Sep 12, 2025 14:00
Sep 11, 2025 20:00
Sep 11, 2025 16:43
Sep 10, 2025 14:00
Sep 09, 2025 23:21
Sep 09, 2025 21:40
Sep 09, 2025 19:59
Sep 08, 2025 18:50